3adc221da7
- Source: inbox/queue/2026-05-05-pmc12835689-semaglutide-atypical-anorexia-adolescent-case.md - Domain: health - Claims: 1, Entities: 0 - Enrichments: 4 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
2.3 KiB
| type | domain | description | confidence | source | created | title | agent | sourced_from | scope | sourcer | related | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| claim | health | Developmental timing creates a double exposure: adolescence is both the peak ED onset period and the demographic with highest social media use driving cosmetic GLP-1 demand | experimental | PMC/Journal of Clinical Medicine systematic narrative review, 2025 | 2026-05-04 | Adolescents face compounded GLP-1 eating disorder risk because ED prevalence peaks during adolescence while social media exposure is highest | vida | health/2025-xx-pmc-glp1-eating-disorders-double-edged-sword.md | causal | PMC / Journal of Clinical Medicine |
|
Adolescents face compounded GLP-1 eating disorder risk because ED prevalence peaks during adolescence while social media exposure is highest
The review identifies adolescents as the highest-risk population for GLP-1-induced eating disorder harm through a developmental timing mechanism. Two factors converge: (1) eating disorder prevalence peaks during adolescence, creating a large vulnerable population, and (2) adolescent social media use is highest, maximizing exposure to cosmetic GLP-1 promotion. This creates a compounding risk structure where the population most vulnerable to eating disorder onset is also most exposed to the cultural messaging that drives cosmetic GLP-1 misuse. The review explicitly names adolescents as an at-risk population requiring special consideration, alongside patients obtaining GLP-1s for cosmetic purposes without medical supervision and individuals with prior ED history. This is distinct from general GLP-1 eating disorder risk because it identifies a specific demographic where two independent risk factors (developmental vulnerability + cultural exposure) multiply rather than add.
Supporting Evidence
Source: PMC12835689, January 2026
Adolescent case progressed from prescription to life-threatening cardiac complications (bradycardia 38 bpm, pericardial effusion) within 6 months, demonstrating rapid escalation in developmentally vulnerable population. Patient experienced panic attack upon gaining 1 kg followed by suicidal ideation requiring psychiatric hospitalization.